Bury Loredana, Falcinelli Emanuela, Gresele Paolo
Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Centro Didattico, Edificio B Piano 1, 06132 Perugia, Italy.
J Clin Med. 2021 Feb 2;10(3):533. doi: 10.3390/jcm10030533.
Inherited thrombocytopenias (IT) are a group of hereditary disorders characterized by a reduced platelet count sometimes associated with abnormal platelet function, which can lead to bleeding but also to syndromic manifestations and predispositions to other disorders. Currently at least 41 disorders caused by mutations in 42 different genes have been described. The pathogenic mechanisms of many forms of IT have been identified as well as the gene variants implicated in megakaryocyte maturation or platelet formation and clearance, while for several of them the pathogenic mechanism is still unknown. A range of therapeutic approaches are now available to improve survival and quality of life of patients with IT; it is thus important to recognize an IT and establish a precise diagnosis. ITs may be difficult to diagnose and an initial accurate clinical evaluation is mandatory. A combination of clinical and traditional laboratory approaches together with advanced sequencing techniques provide the highest rate of diagnostic success. Despite advancement in the diagnosis of IT, around 50% of patients still do not receive a diagnosis, therefore further research in the field of ITs is warranted to further improve patient care.
遗传性血小板减少症(IT)是一组遗传性疾病,其特征为血小板计数减少,有时伴有血小板功能异常,这可能导致出血,还会出现综合征表现以及易患其他疾病。目前已描述了至少41种由42个不同基因突变引起的疾病。许多形式的IT的致病机制已被确定,以及与巨核细胞成熟或血小板形成及清除有关的基因变异,而其中一些疾病的致病机制仍不清楚。现在有一系列治疗方法可用于提高IT患者的生存率和生活质量;因此,识别IT并进行精确诊断很重要。IT可能难以诊断,初步准确的临床评估是必需的。临床和传统实验室方法与先进测序技术相结合可提供最高的诊断成功率。尽管IT的诊断取得了进展,但仍有约50%的患者未得到诊断,因此有必要在IT领域进行进一步研究以进一步改善患者护理。